Supernus Pharmaceuticals Inc: Spn-817 withdrawal rate due to adverse events (AES) is 22% during titration and 2.4% during maintenance
Supernus Pharmaceuticals Inc：由于不良事件（AES）导致的Spn-817停药率在滴定期为22％维护期为2.4％
Supernus Pharmaceuticals Inc: Spn-817 withdrawal rate due to adverse events (AES) is 22% during titration and 2.4% during maintenance
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.